Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals
- PMID: 15466951
- DOI: 10.1080/07315724.2004.10719389
Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals
Abstract
Since Mg(2+)-ATP is the controlling factor for the rate-limiting enzyme in the cholesterol biosynthesis sequence that is targeted by the statin pharmaceutical drugs, comparison of the effects of Mg(2+) on lipoproteins with those of the statin drugs is warranted. Formation of cholesterol in blood, as well as of cholesterol required in hormone synthesis, and membrane maintenance, is achieved in a series of enzymatic reactions that convert HMG-CoA to cholesterol. The rate-limiting reaction of this pathway is the enzymatic conversion of HMG CoA to mevalonate via HMG CoA. The statins and Mg inhibit that enzyme. Large trials have consistently shown that statins, taken by subjects with high LDL-cholesterol (LDL-C) values, lower its blood levels 35 to 65%. They also reduce the incidence of heart attacks, angina and other nonfatal cardiac events, as well as cardiac, stroke, and total mortality. These effects of statins derive less from their lowering of LDL-C than from their reduction of mevalonate formation which improves endothelial function, inhibits proliferation and migration of vascular smooth muscle cells and macrophages, promotes plaque stabilization and regression, and reduces inflammation, Mg has effects that parallel those of statins. For example, the enzyme that deactivates HMG-CoA Reductase requires Mg, making Mg a Reductase controller rather than inhibitor. Mg is also necessary for the activity of lecithin cholesterol acyl transferase (LCAT), which lowers LDL-C and triglyceride levels and raises HDL-C levels. Desaturase is another Mg-dependent enzyme involved in lipid metabolism which statins do not directly affect. Desaturase catalyzes the first step in conversion of essential fatty acids (omega-3 linoleic acid and omega-6 linolenic acid) into prostaglandins, important in cardiovascular and overall health. Mg at optimal cellular concentration is well accepted as a natural calcium channel blocker. More recent work shows that Mg also acts as a statin.
Similar articles
-
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005. Clin Pharmacokinet. 1997. PMID: 9160173 Review.
-
HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.Am J Physiol Renal Physiol. 2005 Mar;288(3):F539-44. doi: 10.1152/ajprenal.00074.2004. Epub 2004 Oct 26. Am J Physiol Renal Physiol. 2005. PMID: 15507547
-
Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.Drugs. 2004;64(11):1181-96. doi: 10.2165/00003495-200464110-00003. Drugs. 2004. PMID: 15161326 Review.
-
Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?Fundam Clin Pharmacol. 2009 Dec;23(6):687-92. doi: 10.1111/j.1472-8206.2009.00745.x. Epub 2009 Aug 14. Fundam Clin Pharmacol. 2009. PMID: 19682084 Review.
-
HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?Herz. 2000 Mar;25(2):117-25. doi: 10.1007/pl00001949. Herz. 2000. PMID: 10829251 Review.
Cited by
-
Association Between Dietary Magnesium Intake with Serum Brain-Derived Neurotrophic Factor (BDNF) and Adropin Levels and Metabolic Health Status in Iranian Adults.Biol Trace Elem Res. 2024 Oct 3. doi: 10.1007/s12011-024-04396-x. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 39361118
-
The Impact of Chronic Magnesium Deficiency on Excitable Tissues-Translational Aspects.Biol Trace Elem Res. 2024 May 6. doi: 10.1007/s12011-024-04216-2. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38709369 Review.
-
Association between Serum Magnesium Levels and Risk of Dyslipidemia: A Cross-Sectional Study from the China Health and Nutrition Survey.Biol Trace Elem Res. 2024 Jun;202(6):2410-2418. doi: 10.1007/s12011-023-03846-2. Epub 2023 Sep 9. Biol Trace Elem Res. 2024. PMID: 37688672
-
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients.Curr Issues Mol Biol. 2023 Apr 5;45(4):3146-3167. doi: 10.3390/cimb45040205. Curr Issues Mol Biol. 2023. PMID: 37185729 Free PMC article. Review.
-
The Role of Magnesium in the Pathogenesis of Metabolic Disorders.Nutrients. 2022 Apr 20;14(9):1714. doi: 10.3390/nu14091714. Nutrients. 2022. PMID: 35565682 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous